{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:43:51Z","timestamp":1782247431218,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bbrc.2024.150262","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T02:49:31Z","timestamp":1719542971000},"page":"150262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The combination of SHP099 inhibits the malignant biological behavior of L-OHP\/5-FU-resistant colorectal cancer cells by regulating energy metabolism reprogramming"],"prefix":"10.1016","volume":"728","author":[{"given":"Meilian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrc.2024.150262_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150262_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bbrc.2024.150262_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/egh.11.67","article-title":"Serrated polyps: critical precursors to colorectal cancer","volume":"5","author":"Sweetser","year":"2011","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150262_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11894-018-0618-9","article-title":"Colorectal cancer in the young","volume":"20","author":"Patel","year":"2018","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"7610","key":"10.1016\/j.bbrc.2024.150262_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nature18621","article-title":"Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases","volume":"535","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbrc.2024.150262_bib6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/neuonc\/noz107","article-title":"Targeting PDGFR\u03b1-activated glioblastoma through specific inhibition of SHP-2-mediated signaling","volume":"21","author":"Sang","year":"2019","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.bbrc.2024.150262_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.apsb.2018.08.009","article-title":"SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade","volume":"9","author":"Zhao","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150262_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.apsb.2021.08.006","article-title":"Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics","volume":"12","author":"Gao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"6487","key":"10.1016\/j.bbrc.2024.150262_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bbrc.2024.150262_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.768861","article-title":"The crosstalk between signaling pathways and cancer metabolism in colorectal cancer","volume":"12","author":"Hon","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150262_bib11","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-019-11274-x","article-title":"ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy","volume":"10","author":"Tian","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbrc.2024.150262_bib12","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/cas.14532","article-title":"5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes","volume":"111","author":"Blondy","year":"2020","journal-title":"Cancer Sci."},{"issue":"14","key":"10.1016\/j.bbrc.2024.150262_bib13","doi-asserted-by":"crossref","first-page":"11559","DOI":"10.18632\/oncotarget.24338","article-title":"5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer","volume":"9","author":"Morawska","year":"2018","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbrc.2024.150262_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/bjc.2017.38","article-title":"Oncogenic role of PDK4 in human colon cancer cells","volume":"116","author":"Leclerc","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.bbrc.2024.150262_bib15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.15252\/emmm.201505492","article-title":"PHD1 regulates p53-mediated colorectal cancer chemoresistance","volume":"7","author":"Deschoemaeker","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2024.150262_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152882","article-title":"Oxaliplatin-induced hepatic sinusoidal obstruction syndrome","volume":"460","author":"Zhu","year":"2021","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.bbrc.2024.150262_bib17","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","article-title":"Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment","volume":"268","author":"Kang","year":"2021","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.bbrc.2024.150262_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001240","article-title":"Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial","volume":"8","author":"Chen","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"15","key":"10.1016\/j.bbrc.2024.150262_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155353","article-title":"MicroRNAs and apoptosis in colorectal cancer","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150262_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.bbrc.2024.150262_bib21","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/DDDT.S132488","article-title":"Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2\/STAT3 and PI3K\/Akt\/NF\u03baB pathways in cholangiocarcinoma cells","volume":"11","author":"Ke","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150262_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"2","key":"10.1016\/j.bbrc.2024.150262_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020089","article-title":"Metabolic reprogramming in breast cancer and its therapeutic implications","volume":"8","author":"Gandhi","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bbrc.2024.150262_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","article-title":"Metabolic codependencies in the tumor microenvironment","volume":"11","author":"Dey","year":"2021","journal-title":"Cancer Discov."},{"issue":"10207","key":"10.1016\/j.bbrc.2024.150262_bib25","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150262_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"Ca - Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.bbrc.2024.150262_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.4143\/crt.2019.593","article-title":"CXCL-13 regulates resistance to 5-fluorouracil in colorectal cancer","volume":"52","author":"Zhang","year":"2020","journal-title":"Cancer Res. Treatment"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150262_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.30989","article-title":"Overriding adaptive resistance to sorafenib through combination therapy with src homology 2 domain-containing phosphatase 2 blockade in hepatocellular carcinoma","volume":"72","author":"Leung","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.150262_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115053","article-title":"ATPR induces acute promyelocytic leukemia cells differentiation and growth arrest by blockade of SHP2\/Rho\/ROCK1 pathway","volume":"399","author":"Li","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbrc.2024.150262_bib30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/2159-8290.CD-18-0444","article-title":"SHP2 inhibition prevents adaptive resistance to MEK inhibitors in multiple cancer models","volume":"8","author":"Fedele","year":"2018","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.bbrc.2024.150262_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun."},{"issue":"12","key":"10.1016\/j.bbrc.2024.150262_bib32","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.1007\/s11033-021-06769-0","article-title":"Intracellular metabolic reprogramming mediated by micro-RNAs in differentiating and proliferating cells under non-diseased conditions","volume":"48","author":"Singh","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbrc.2024.150262_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathol-012615-044329","article-title":"Metabolic reprogramming in brain tumors","volume":"12","author":"Venneti","year":"2017","journal-title":"Ann. Rev. Pathology"},{"issue":"8","key":"10.1016\/j.bbrc.2024.150262_bib34","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbabio.2016.02.004","article-title":"The ATPase Inhibitory Factor 1 (IF1): a master regulator of energy metabolism and of cell survival","volume":"1857","author":"Garc\u00edA-Berm\u00faDEZ","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bbrc.2024.150262_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111204","article-title":"Mitochondrial microproteins link metabolic cues to respiratory chain biogenesis","volume":"40","author":"Liang","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150262_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.bbrc.2024.150262_bib37","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1172\/JCI57909","article-title":"Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers","volume":"121","author":"Ebi","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150262_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-021-01474-9","article-title":"CircIL4R activates the PI3K\/AKT signaling pathway via the miR-761\/TRIM29\/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer","volume":"20","author":"Jiang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2024.150262_bib39","article-title":"Promethazine inhibits proliferation and promotes apoptosis in colorectal cancer cells by suppressing the PI3K\/AKT pathway","volume":"143","author":"Tan","year":"2021","journal-title":"Biomed. & Pharmacotherapy = Biomed. & Pharmacotherapie"},{"key":"10.1016\/j.bbrc.2024.150262_bib40","article-title":"Therapeutic suppression of FAK-AKT signaling overcomes resistance to SHP2 inhibition in colorectal carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24007988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24007988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T04:51:44Z","timestamp":1722660704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24007988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":40,"alternative-id":["S0006291X24007988"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150262","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2740638\/v1","asserted-by":"object"}]},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination of SHP099 inhibits the malignant biological behavior of L-OHP\/5-FU-resistant colorectal cancer cells by regulating energy metabolism reprogramming","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150262"}}